Contact information
Research groups
Amy Flaxman
Recent publications
-
Safety and immunogenicity of a candidate Middle East respiratory syndrome coronavirus viral-vectored vaccine: a dose-escalation, open-label, non-randomised, uncontrolled, phase 1 trial.
Journal article
Folegatti PM. et al, (2020), The Lancet. Infectious diseases, 20, 816 - 826
-
A Multi-Filovirus Vaccine Candidate: Co-Expression of Ebola, Sudan, and Marburg Antigens in a Single Vector
Journal article
Sebastian S. et al, (2020), Vaccines, 8, 241 - 241
-
Safety and Immunogenicity of the Heterosubtypic Influenza A Vaccine MVA-NP+M1 Manufactured on the AGE1.CR.pIX Avian Cell Line
Journal article
Folegatti PM. et al, (2019), Vaccines, 7, 33 - 33
-
Heterogeneous early immune responses to the S. aureus EapH2 antigen induced by gastrointestinal tract colonisation impact the response to subsequent vaccination
Journal article
Flaxman A. et al, (2019), Vaccine, 37, 494 - 501
-
Vaccination with the Staphylococcus aureus secreted proteins EapH1 and EapH2 impacts both S. aureus carriage and invasive disease
Journal article
Elshina E. et al, (2019), Vaccine, 37, 502 - 509